green vital glp-1 Nestlé Health Science unveils nutrition support platform GLP-1 Metabolic Support Supplement –

Additionally, lixisenatide was associated with fewer gastrointestinal symptoms compared to exenatide, while long-acting GLP-1RAs generally caused less nausea and vomiting but more diarrhea than short-acting agents (49)

Michael White, head of the department of pharmacy practice at the University of Connecticut, there are currently no GLP-1 medications that can be absorbed through the skin

Hypoglycemia Increased heart rate Potential pancreatitis Gallbladder issues Acute kidney injury Risk of thyroid tumors It is recommended that patients be monitored for these risks, especially those with a history of thyroid disease

Common gastrointestinal side effects: The most frequently reported adverse effects are gastrointestinal in nature, occurring in up to 40-80% of patients with higher doses, particularly during dose escalation: [13] [14] Nausea (most common, typically improves after 4-8 weeks) Vomiting Diarrhoea or constipation Abdominal discomfort or bloating Reduced appetite These effects can be minimised by starting with low doses and gradually titrating upwards according to manufacturer guidance